We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
International Bancshares
IBOC
$4.77B
| $422K | ﹤0.01% |
10,630
-3,600
| -25% | -$145K |
|
1827
Bristow Group
VTOL
$1.35B
| $422K | ﹤0.01% |
19,650
+1,150
| +6% | +$24.2K |
|
1828
Warner Bros
WBD
$64.6B
| $417K | ﹤0.01% |
18,612
-103,800
| -85% | -$2.03M |
|
|
CTT
1829
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $417K | ﹤0.01% |
31,749
+15,400
| +94% | +$199K |
|
|
LHCG
1830
DELISTED
LHC Group LLC
LHCG
| $416K | ﹤0.01% |
6,791
-38,500
| -85% | -$2.54M |
|
|
NXEO
1831
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $416K | ﹤0.01% |
+45,737
| New | +$361K |
|
|
NSU
1832
DELISTED
Nevsun Resources Ltd.
NSU
| $416K | ﹤0.01% |
170,531
+48,000
| +39% | +$111K |
|
1833
AptarGroup
ATR
$8.45B
| $414K | ﹤0.01% |
+4,804
| New | +$419K |
|
|
TUES
1834
DELISTED
Tuesday Morning Corp
TUES
| $414K | ﹤0.01% |
150,699
+65,700
| +77% | +$185K |
|
|
KANG
1835
DELISTED
iKang Healthcare Group, Inc.
KANG
| $414K | ﹤0.01% |
+26,200
| New | +$379K |
|
1836
Gorman-Rupp
GRC
$2.16B
| $413K | ﹤0.01% |
13,227
-2,300
| -15% | -$73K |
|
|
AKS
1837
DELISTED
AK Steel Holding Corp
AKS
| $408K | ﹤0.01% |
72,047
-262,700
| -78% | -$1.37M |
|
|
CSR
1838
Centerspace
CSR
$936M
| $407K | ﹤0.01% |
7,165
+2,405
| +51% | +$143K |
|
|
ICD
1839
DELISTED
Independence Contract Drilling, Inc.
ICD
| $407K | ﹤0.01% |
5,119
-1,540
| -23% | -$112K |
|
|
VIA
1840
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $407K | ﹤0.01% |
6,567
+100
| +2% | +$6.57K |
|
|
BFS
1841
Saul Centers
BFS
$875M
| $402K | ﹤0.01% |
6,511
-400
| -6% | -$25K |
|
1842
Liquidity Services
LQDT
$1.17B
| $402K | ﹤0.01% |
82,818
-10,300
| -11% | -$56.1K |
|
1843
RenaissanceRe
RNR
$13.7B
| $402K | ﹤0.01% |
+3,200
| New | +$430K |
|
1844
TechTarget
TTGT
$246M
| $402K | ﹤0.01% |
28,879
+1,700
| +6% | +$22.1K |
|
1845
Bank of Marin Bancorp
BMRC
$466M
| $401K | ﹤0.01% |
11,790
+600
| +5% | +$20.7K |
|
|
REVG
1846
DELISTED
REV Group
REVG
| $401K | ﹤0.01% |
+12,314
| New | +$338K |
|
|
ZAGG
1847
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $401K | ﹤0.01% |
21,754
-4,800
| -18% | -$89.8K |
|
1848
Nathan's Famous
NATH
$402M
| $400K | ﹤0.01% |
5,300
+1,200
| +29% | +$102K |
|
1849
Rigel Pharmaceuticals
RIGL
$680M
| $399K | ﹤0.01% |
10,279
+2,400
| +30% | +$91.3K |
|
|
MIC
1850
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $398K | ﹤0.01% |
+6,205
| New | +$420K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.